LAMA-84 |
Growth Inhibition Assay |
|
|
|
IC50=0.07304 μM |
SANGER |
EM-2 |
Growth Inhibition Assay |
|
|
|
IC50=0.0888 μM |
SANGER |
MEG-01 |
Growth Inhibition Assay |
|
|
|
IC50=0.08921 μM |
SANGER |
BV-173 |
Growth Inhibition Assay |
|
|
|
IC50=0.1874 μM |
SANGER |
K-562 |
Growth Inhibition Assay |
|
|
|
IC50=0.22432 μM |
SANGER |
CGTH-W-1 |
Growth Inhibition Assay |
|
|
|
IC50=0.38374 μM |
SANGER |
ST486 |
Growth Inhibition Assay |
|
|
|
IC50=0.6854 μM |
SANGER |
NCI-H1436 |
Growth Inhibition Assay |
|
|
|
IC50=0.97801 μM |
SANGER |
NOS-1 |
Growth Inhibition Assay |
|
|
|
IC50=1.65383 μM |
SANGER |
A498 |
Growth Inhibition Assay |
|
|
|
IC50=2.57223 μM |
SANGER |
BE-13 |
Growth Inhibition Assay |
|
|
|
IC50=2.62106 μM |
SANGER |
SUP-T1 |
Growth Inhibition Assay |
|
|
|
IC50=3.82907 μM |
SANGER |
NCI-H1770 |
Growth Inhibition Assay |
|
|
|
IC50=5.57262 μM |
SANGER |
IMR-5 |
Growth Inhibition Assay |
|
|
|
IC50=6.22147 μM |
SANGER |
LB2241-RCC |
Growth Inhibition Assay |
|
|
|
IC50=8.07384 μM |
SANGER |
TGBC24TKB |
Growth Inhibition Assay |
|
|
|
IC50=8.34052 μM |
SANGER |
SCC-15 |
Growth Inhibition Assay |
|
|
|
IC50=10.7788 μM |
SANGER |
BB49-HNC |
Growth Inhibition Assay |
|
|
|
IC50=14.3335 μM |
SANGER |
ES7 |
Growth Inhibition Assay |
|
|
|
IC50=14.7379 μM |
SANGER |
LB2518-MEL |
Growth Inhibition Assay |
|
|
|
IC50=16.6094 μM |
SANGER |
NCI-H510A |
Growth Inhibition Assay |
|
|
|
IC50=17.2442 μM |
SANGER |
TE-441-T |
Growth Inhibition Assay |
|
|
|
IC50=17.2886 μM |
SANGER |
HH |
Growth Inhibition Assay |
|
|
|
IC50=17.3999 μM |
SANGER |
LC4-1 |
Growth Inhibition Assay |
|
|
|
IC50=18.0652 μM |
SANGER |
KARPAS-45 |
Growth Inhibition Assay |
|
|
|
IC50=18.1848 μM |
SANGER |
LB1047-RCC |
Growth Inhibition Assay |
|
|
|
IC50=18.4452 μM |
SANGER |
NKM-1 |
Growth Inhibition Assay |
|
|
|
IC50=19.3552 μM |
SANGER |
SCLC-21H |
Growth Inhibition Assay |
|
|
|
IC50=20.1246 μM |
SANGER |
RS4-11 |
Growth Inhibition Assay |
|
|
|
IC50=20.3308 μM |
SANGER |
ALL-PO |
Growth Inhibition Assay |
|
|
|
IC50=20.8149 μM |
SANGER |
GDM-1 |
Growth Inhibition Assay |
|
|
|
IC50=22.5945 μM |
SANGER |
DMS-79 |
Growth Inhibition Assay |
|
|
|
IC50=24.4934 μM |
SANGER |
MPP-89 |
Growth Inhibition Assay |
|
|
|
IC50=25.6874 μM |
SANGER |
NB10 |
Growth Inhibition Assay |
|
|
|
IC50=26.4699 μM |
SANGER |
LS-513 |
Growth Inhibition Assay |
|
|
|
IC50=26.8847 μM |
SANGER |
L-540 |
Growth Inhibition Assay |
|
|
|
IC50=26.9143 μM |
SANGER |
ES1 |
Growth Inhibition Assay |
|
|
|
IC50=27.521 μM |
SANGER |
NTERA-S-cl-D1 |
Growth Inhibition Assay |
|
|
|
IC50=30.5093 μM |
SANGER |
EW-1 |
Growth Inhibition Assay |
|
|
|
IC50=32.9454 μM |
SANGER |
Calu-6 |
Growth Inhibition Assay |
|
|
|
IC50=33.1855 μM |
SANGER |
CTV-1 |
Growth Inhibition Assay |
|
|
|
IC50=33.9789 μM |
SANGER |
YT |
Growth Inhibition Assay |
|
|
|
IC50=38.5209 μM |
SANGER |
TE-6 |
Growth Inhibition Assay |
|
|
|
IC50=41.2798 μM |
SANGER |
HT-144 |
Growth Inhibition Assay |
|
|
|
IC50=41.5486 μM |
SANGER |
EW-13 |
Growth Inhibition Assay |
|
|
|
IC50=42.2791 μM |
SANGER |
KALS-1 |
Growth Inhibition Assay |
|
|
|
IC50=43.1329 μM |
SANGER |
MOLT-16 |
Growth Inhibition Assay |
|
|
|
IC50=45.0752 μM |
SANGER |
D-336MG |
Growth Inhibition Assay |
|
|
|
IC50=45.9599 μM |
SANGER |
TE-11 |
Growth Inhibition Assay |
|
|
|
IC50=46.653 μM |
SANGER |
EB2 |
Growth Inhibition Assay |
|
|
|
IC50=46.699 μM |
SANGER |
SK-N-DZ |
Growth Inhibition Assay |
|
|
|
IC50=48.0961 μM |
SANGER |
SW684 |
Growth Inhibition Assay |
|
|
|
IC50=48.2695 μM |
SANGER |
EW-18 |
Growth Inhibition Assay |
|
|
|
IC50=48.4395 μM |
SANGER |
RL95-2 |
Growth Inhibition Assay |
|
|
|
IC50=50.071 μM |
SANGER |
CHP-126 |
Growth Inhibition Assay |
|
|
|
IC50=50.8905 μM |
SANGER |
NCI-H1395 |
Growth Inhibition Assay |
|
|
|
IC50=51.7835 μM |
SANGER |
TE-15 |
Growth Inhibition Assay |
|
|
|
IC50=52.2556 μM |
SANGER |
ES4 |
Growth Inhibition Assay |
|
|
|
IC50=52.9775 μM |
SANGER |
TE-1 |
Growth Inhibition Assay |
|
|
|
IC50=53.9455 μM |
SANGER |
SIMA |
Growth Inhibition Assay |
|
|
|
IC50=57.3311 μM |
SANGER |
LB647-SCLC |
Growth Inhibition Assay |
|
|
|
IC50=64.1188 μM |
SANGER |
KY821 |
Growth Inhibition Assay |
|
|
|
IC50=64.2552 μM |
SANGER |
LC-2-ad |
Growth Inhibition Assay |
|
|
|
IC50=65.7601 μM |
SANGER |
KP-N-RT-BM-1 |
Growth Inhibition Assay |
|
|
|
IC50=66.6366 μM |
SANGER |
SW872 |
Growth Inhibition Assay |
|
|
|
IC50=67.4382 μM |
SANGER |
ES5 |
Growth Inhibition Assay |
|
|
|
IC50=67.6968 μM |
SANGER |
SK-NEP-1 |
Growth Inhibition Assay |
|
|
|
IC50=68.3803 μM |
SANGER |
RPMI-6666 |
Growth Inhibition Assay |
|
|
|
IC50=71.032 μM |
SANGER |
UACC-812 |
Growth Inhibition Assay |
|
|
|
IC50=71.1609 μM |
SANGER |
COLO-829 |
Growth Inhibition Assay |
|
|
|
IC50=72.6987 μM |
SANGER |
KP-N-YS |
Growth Inhibition Assay |
|
|
|
IC50=72.7139 μM |
SANGER |
GI-1 |
Growth Inhibition Assay |
|
|
|
IC50=73.2868 μM |
SANGER |
ETK-1 |
Growth Inhibition Assay |
|
|
|
IC50=73.4932 μM |
SANGER |
LXF-289 |
Growth Inhibition Assay |
|
|
|
IC50=73.729 μM |
SANGER |
CAS-1 |
Growth Inhibition Assay |
|
|
|
IC50=73.8857 μM |
SANGER |
EW-22 |
Growth Inhibition Assay |
|
|
|
IC50=74.7115 μM |
SANGER |
NCI-H2196 |
Growth Inhibition Assay |
|
|
|
IC50=75.6379 μM |
SANGER |
EoL-1-cell |
Growth Inhibition Assay |
|
|
|
IC50=81.6963 μM |
SANGER |
D-247MG |
Growth Inhibition Assay |
|
|
|
IC50=82.0248 μM |
SANGER |
Becker |
Growth Inhibition Assay |
|
|
|
IC50=82.3481 μM |
SANGER |
IST-MEL1 |
Growth Inhibition Assay |
|
|
|
IC50=82.3482 μM |
SANGER |
MDA-MB-134-VI |
Growth Inhibition Assay |
|
|
|
IC50=82.5996 μM |
SANGER |
NCI-H1092 |
Growth Inhibition Assay |
|
|
|
IC50=84.0197 μM |
SANGER |
KINGS-1 |
Growth Inhibition Assay |
|
|
|
IC50=86.1618 μM |
SANGER |
HCC2218 |
Growth Inhibition Assay |
|
|
|
IC50=86.7913 μM |
SANGER |
GI-ME-N |
Growth Inhibition Assay |
|
|
|
IC50=87.7699 μM |
SANGER |
AM-38 |
Growth Inhibition Assay |
|
|
|
IC50=88.3953 μM |
SANGER |
KNS-42 |
Growth Inhibition Assay |
|
|
|
IC50=89.1018 μM |
SANGER |
C8166 |
Growth Inhibition Assay |
|
|
|
IC50=89.6125 μM |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition Assay |
|
|
|
IC50=89.8719 μM |
SANGER |
CTB-1 |
Growth Inhibition Assay |
|
|
|
IC50=90.6357 μM |
SANGER |
HCE-4 |
Growth Inhibition Assay |
|
|
|
IC50=91.1336 μM |
SANGER |
NCI-H526 |
Growth Inhibition Assay |
|
|
|
IC50=92.4103 μM |
SANGER |
ECC4 |
Growth Inhibition Assay |
|
|
|
IC50=94.2555 μM |
SANGER |
NCCIT |
Growth Inhibition Assay |
|
|
|
IC50=95.3292 μM |
SANGER |
MZ7-mel |
Growth Inhibition Assay |
|
|
|
IC50=95.904 μM |
SANGER |
COLO-684 |
Growth Inhibition Assay |
|
|
|
IC50=96.2385 μM |
SANGER |
SU-DHL-1 |
Growth Inhibition Assay |
|
|
|
IC50=96.9842 μM |
SANGER |
SF126 |
Growth Inhibition Assay |
|
|
|
IC50=97.5217 μM |
SANGER |
NMC-G1 |
Growth Inhibition Assay |
|
|
|
IC50=98.4554 μM |
SANGER |
NB14 |
Growth Inhibition Assay |
|
|
|
IC50=98.9208 μM |
SANGER |
VA-ES-BJ |
Growth Inhibition Assay |
|
|
|
IC50=99.4056 μM |
SANGER |
CHO |
Function assay |
|
|
|
Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells, IC50=0.24μM. |
12166950 |
CHO |
Function assay |
|
|
|
Inhibition of chimeric PDGF receptor with c-kit cytoplasmic domain phosphorylation in CHO cells, IC50=0.26μM. |
12166950 |
CHO |
Function assay |
|
|
|
Inhibition of chimeric PDGF receptor with CSF-1R cytoplasmic domain phosphorylation in CHO cells, IC50=0.96μM. |
12166950 |
K562 |
Cytotoxicity assay |
|
|
|
Cytotoxic effect in K562 cells, IC50=0.11μM. |
12951113 |
K562 |
Function assay |
|
|
|
Inhibitory activity against human K562 cells growth using MTT assay, IC50=0.4μM. |
14552760 |
Sf9 |
Function assay |
|
|
|
TP_TRANSPORTER: inhibition of ATPase activity in BCRP-expressing Sf9 cells, IC50=0.5μM. |
15155841 |
Sf9 |
Function assay |
|
|
|
TP_TRANSPORTER: efflux of Hoechst33342 in BCRP-expressing Sf9 cells, IC50=0.9μM. |
15155841 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against K562 cells, IC50=0.182μM. |
16332440 |
U937 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against U937 cells, IC50=14μM. |
16332440 |
BA/F3 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against mouse BA/F3 Bcr-abl negative cells expressing Tel-PDGFRbeta kinase assessed as proliferation after 48 hrs by MTT assay, IC50=0.027μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
5 to 10 uM |
48 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Tel-SH2-KD assessed as cell viability at 5 to 10 uM after 48 hrs by MTT assay, IC50=0.055μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
5 to 10 uM |
48 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Tel-SH3-SH2-KD assessed as cell viability at 5 to 10 uM after 48 hrs by MTT assay, IC50=0.088μM. |
16415863 |
32D |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against mouse 32D cells transfected with p210 cells expressing Bcr-abl assessed as proliferation after 48 hrs by MTT assay, IC50=0.112μM. |
16415863 |
32D |
Cytotoxicity assay |
|
|
|
Cytotoxic activity against mouse 32D cells transfected with p210 Bcr-abl, IC50=0.19μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferation activity against mouse BA/F3 cells expressing Bcr-abl assessed as cell viability after 48 hrs by MTT assay, IC50=0.19μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against mouse BA/F3 cells transfected with p210 Bcr-abl assessed as proliferation after 48 hrs by MTT assay, IC50=0.19μM. |
16415863 |
M07e |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human M07e Bcr-abl negative cells expressing stem cell factor assessed as proliferation after 48 hrs by MTT assay, IC50=0.257μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferation activity against mouse BA/F3 cells expressing Bcr-abl A337N mutant assessed as cell viability after 48 hrs by MTT assay, IC50=0.339μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
5 to 10 uM |
48 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing NPM-abl assessed as cell viability at 5 to 10 uM after 48 hrs by MTT assay, IC50=0.393μM. |
16415863 |
BA/F3 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferation activity against mouse BA/F3 cells expressing Bcr-abl A334l mutant assessed as cell viability after 48 hrs by MTT assay, IC50=0.962μM. |
16415863 |
32D |
Cytotoxicity assay |
|
|
|
Cytotoxic activity against mouse 32D Bcr-abl negative cells, IC50=20μM. |
16415863 |
BaF3 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against murine BaF3 cells expressing wild type NPM/ALK by [3H]thymidine uptake assay, IC50=7.1μM. |
16970400 |
BaF3 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against murine BaF3 cells expressing NPM/ALK L256T mutant by [3H]thymidine uptake assay, IC50=9.1μM. |
16970400 |
Vero |
Antiviral assay |
|
3 days |
|
Antiviral activity against Dengue virus infected in african green monkey Vero cells administered before viral challenge after 3 days by viral plaque assay |
17360676 |
Sf9 |
Function assay |
|
|
|
Inhibition of human Lyn kinase expressed in Sf9 cells, IC50=0.22μM. |
17376680 |
Sf9 |
Function assay |
|
|
|
Inhibition of human Abl kinase expressed in Sf9 cells, IC50=0.47μM. |
17376680 |
K562 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against K562 cells by MTT assay, IC50=0.18μM. |
17572088 |
A2780/ADR |
Function assay |
|
|
|
Inhibition of P-glycoprotein expressed in A2780/ADR cells by calcein AM assay, IC50=7.24436μM. |
17890094 |
MO7e |
Function assay |
|
|
|
Inhibition of SCF-induced phosphorylation of c-Kit in MO7e cells by TR-FRET assay, IC50=0.046μM. |
18447379 |
MCF7 |
Function assay |
|
|
|
Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay, IC50=4.89779μM. |
18678495 |
A2780 |
Function assay |
|
|
|
Inhibition of P-gp in human adriamycin-resistant A2780 cells by Hoechst 33342 assay, IC50=7.24436μM. |
18678495 |
CML |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human CML cells, IC50=0.35μM. |
19219016 |
EOL-1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human EOL-1 cells after 72 hrs by alamar-blue cell viability assay, IC50=0.0001995μM. |
19301902 |
EOL-1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human EOL-1 cells after 72 hrs by alamar-blue cell viability assay, IC50=0.0002μM. |
19301902 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells after 72 hrs by alamar-blue cell viability assay, IC50=0.049μM. |
19301902 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells after 72 hrs by alamar-blue cell viability assay, IC50=0.1μM. |
19301902 |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HCT116 cells after 72 hrs by alamar-blue cell viability assay, IC50=10μM. |
19301902 |
RKOp21 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human RKOp21 cells after 72 hrs by alamar-blue cell viability assay, IC50=12μM. |
19301902 |
RKOp21 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human RKOp21 cells after 72 hrs by alamar-blue cell viability assay, IC50=12.5892μM. |
19301902 |
A549 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A549 cells after 72 hrs by alamar-blue cell viability assay, IC50=15.5μM. |
19301902 |
MDA-MB-468 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MDA-MB-468 cells after 72 hrs by alamar-blue cell viability assay, IC50=15.8489μM. |
19301902 |
MDA-MB-468 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MDA-MB-468 cells after 72 hrs by alamar-blue cell viability assay, IC50=17μM. |
19301902 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HeLa cells after 72 hrs by alamar-blue cell viability assay, IC50=18.65μM. |
19301902 |
Hec1A |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human Hec1A cells after 72 hrs by alamar-blue cell viability assay, IC50=19μM. |
19301902 |
A549 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A549 cells after 72 hrs by alamar-blue cell viability assay, IC50=19.9526μM. |
19301902 |
CAL27 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human CAL27 cells after 72 hrs by alamar-blue cell viability assay, IC50=19.9526μM. |
19301902 |
Hec1A |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human Hec1A cells after 72 hrs by alamar-blue cell viability assay, IC50=19.9526μM. |
19301902 |
CAL27 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human CAL27 cells after 72 hrs by alamar-blue cell viability assay, IC50=22μM. |
19301902 |
H460 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human H460 cells after 72 hrs by alamar-blue cell viability assay, IC50=24μM. |
19301902 |
PC3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human PC3 cells after 72 hrs by alamar-blue cell viability assay, IC50=24μM. |
19301902 |
HCT15 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HCT15 cells after 72 hrs by alamar-blue cell viability assay, IC50=25μM. |
19301902 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HeLa cells after 72 hrs by alamar-blue cell viability assay, IC50=25.1189μM. |
19301902 |
H460 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human H460 cells after 72 hrs by alamar-blue cell viability assay, IC50=25.1189μM. |
19301902 |
HCT15 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HCT15 cells after 72 hrs by alamar-blue cell viability assay, IC50=25.1189μM. |
19301902 |
PC3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human PC3 cells after 72 hrs by alamar-blue cell viability assay, IC50=25.1189μM. |
19301902 |
Saos2 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human Saos2 cells after 72 hrs by alamar-blue cell viability assay, IC50=25.1189μM. |
19301902 |
Saos2 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human Saos2 cells after 72 hrs by alamar-blue cell viability assay, IC50=26μM. |
19301902 |
MCF7 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MCF7 cells after 72 hrs by alamar-blue cell viability assay, IC50=30μM. |
19301902 |
A431 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A431 cells after 72 hrs by alamar-blue cell viability assay, IC50=31μM. |
19301902 |
H69 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human H69 cells after 72 hrs by alamar-blue cell viability assay, IC50=31.6228μM. |
19301902 |
MCF7 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MCF7 cells after 72 hrs by alamar-blue cell viability assay, IC50=31.6228μM. |
19301902 |
A431 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A431 cells after 72 hrs by alamar-blue cell viability assay, IC50=31.6228μM. |
19301902 |
H69 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human H69 cells after 72 hrs by alamar-blue cell viability assay, IC50=32μM. |
19301902 |
CCRF-CEM |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human CCRF-CEM cells after 72 hrs by alamar-blue cell viability assay, IC50=36μM. |
19301902 |
MDA-MB-231 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by alamar-blue cell viability assay, IC50=37μM. |
19301902 |
CCRF-CEM/VCR1000 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against vincristine-resistant human CCRF-CEM/VCR1000 cells after 72 hrs by alamar-blue cell viability assay, IC50=37μM. |
19301902 |
WM266.4 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human WM266.4 cells after 72 hrs by alamar-blue cell viability assay, IC50=37μM. |
19301902 |
U87MG |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay, IC50=38μM. |
19301902 |
SKBR3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human SKBR3 cells after 72 hrs by alamar-blue cell viability assay, IC50=39μM. |
19301902 |
MDA-MB-231 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
SKBR3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human SKBR3 cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
AsPC1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human AsPC1 cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
CCRF-CEM/VCR1000 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against vincristine-resistant human CCRF-CEM/VCR1000 cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
CCRF-CEM |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human CCRF-CEM cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
U87MG |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
WM266.4 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human WM266.4 cells after 72 hrs by alamar-blue cell viability assay, IC50=39.8107μM. |
19301902 |
AsPC1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human AsPC1 cells after 72 hrs by alamar-blue cell viability assay, IC50=44μM. |
19301902 |
A2780 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A2780 cells after 72 hrs by alamar-blue cell viability assay, IC50=48μM. |
19301902 |
HT-29 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human HT-29 cells after 96 hrs by SRB assay, IC50=0.06μM. |
19469547 |
GIST882 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human GIST882 cells after 96 hrs by SRB assay, IC50=1.7μM. |
19469547 |
HGC27 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human HGC27 cells after 96 hrs by SRB assay, IC50=2.4μM. |
19469547 |
MCF7 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human MCF7 cells after 96 hrs by SRB assay, IC50=11.5μM. |
19469547 |
GIST48 |
Cytotoxicity assay |
|
3 to 6 days |
|
Cytotoxicity against human GIST48 cells assessed as effect on cell viability after 3 to 6 days by luciferase based luminescence assay, IC50=18.7μM. |
19469547 |
ALL3 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against Philadelphia chromosome positive human ALL3 cells by Alamar Blue fluorescent assay, IC50=0.333μM. |
19889540 |
MDCK |
Function assay |
|
|
|
Inhibition of BCRP expressed in MDCK cells by pheophorbide A assay, IC50=3.38μM. |
19932960 |
MCF7 MX |
Function assay |
|
|
|
Inhibition of BCRP expressed in MCF7 MX cells by Hoechst 33342 staining, IC50=4.07μM. |
19932960 |
KBM5 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human KBM5 cells harboring wild type Bcr-Abl after 72 hrs by MTT assay, IC50=0.28μM. |
20149665 |
KBM5 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human KBM5 cells harboring Bcr-Abl T315I mutant after 72 hrs by MTT assay, IC50=5.4μM. |
20149665 |
FDC-P1 |
Function assay |
|
48 hrs |
|
Inhibition of human FMS expressed in growth factor dependent mouse FDC-P1 cells assessed as inhibition of FMS-mediated cell proliferation in presence human CSF1 after 48 hrs by resazurin dye reduction assay, IC50=1.274μM. |
20156689 |
FDC-P1 |
Function assay |
|
48 hrs |
|
Inhibition of mouse GM-CSF-stimulated cell proliferation of growth factor dependent mouse FDC-P1 cells expressing human FMS after 48 hrs by resazurin dye reduction assay, IC50=8.437μM. |
20156689 |
K562 |
Function assay |
|
2 hrs |
|
Inhibition of BCR/ABL p210 autophosphorylation in human K562 cells after 2 hrs by Western blot analysis, IC50=0.75μM. |
20188579 |
BESM |
Antitrypanosomal assay |
|
88 hrs |
|
Antitrypanosomal activity against Trypanosoma cruzi amastigotes infected in BESM cells measured after 88 hrs postinfection by HTS assay, EC50=9μM. |
20547819 |
BESM |
Cytotoxicity assay |
|
88 hrs |
|
Cytotoxicity against BESM cells after 88 hrs by HTS assay, EC50=32μM. |
20547819 |
BA/F3 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against PDGFRbeta transfected mouse BA/F3 cells, IC50=0.039μM. |
20817538 |
HEK293 |
Function assay |
|
|
|
Inhibition of autophosphorylation of DDR1 expressed in HEK293 cells by ELISA, IC50=0.043μM. |
20817538 |
A31 |
Function assay |
|
|
|
Inhibition of human PDGFRalpha autophosphorylation in human A31 cells by ELISA, IC50=0.072μM. |
20817538 |
A31 |
Function assay |
|
|
|
Inhibition of PDGFRbeta autophosphorylation in human A31 cells by ELISA, IC50=0.072μM. |
20817538 |
GIST882 |
Function assay |
|
|
|
Inhibition of human KIT autophosphorylation in human GIST882 cells by ELISA, IC50=0.097μM. |
20817538 |
GIST882 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST882 cells, IC50=0.108μM. |
20817538 |
HEK293 |
Function assay |
|
|
|
Inhibition of autophosphorylation of DDR2 expressed in HEK293 cells by ELISA, IC50=0.141μM. |
20817538 |
Ba/F |
Function assay |
|
|
|
Inhibition of autophosphorylation of BCR-ABL1 expressed in Ba/F cells, IC50=0.221μM. |
20817538 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human K562 cells, IC50=0.244μM. |
20817538 |
HEK293 |
Function assay |
|
|
|
Inhibition of autophosphorylation of CSF1R expressed in HEK293 cells by ELISA, IC50=0.291μM. |
20817538 |
M-NFS-60 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against mouse M-NFS-60 cells, IC50=0.358μM. |
20817538 |
K562 |
Function assay |
|
|
|
Inhibition of BCR-ABL1 autophosphorylation in human K562 cells, IC50=0.473μM. |
20817538 |
BA/F3 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against BCR-ABL1 transfected mouse BA/F3 cells, IC50=0.678μM. |
20817538 |
BA/F3 |
Antiproliferative assay |
|
|
|
Antiproliferative activity mouse BA/F3 cells in presence of interleukin 3, IC50=9.459μM. |
20817538 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay, IC50=0.58μM. |
21295380 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human imatinib-resistant K562 cells, IC50=0.00605μM. |
21376587 |
KU812 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human KU812 cells, IC50=0.337μM. |
21376587 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human K562 cells, IC50=0.38μM. |
21376587 |
Sf9 |
Function assay |
|
|
|
Binding affinity to human active site of N-terminal hexahistidine-tagged ABL2 expressed in Trichoplusia ni infected Sf9 cells by isothermal titration calorimetric assay, Kd=0.006μM. |
21417343 |
Sf9 |
Function assay |
|
|
|
Binding affinity to human remote site of N-terminal hexahistidine-tagged ABL2 expressed in Trichoplusia ni infected Sf9 cells by isothermal titration calorimetric assay, Kd=0.5μM. |
21417343 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=5.4μM. |
21576023 |
Ba/F3 |
Function assay |
1 uM |
24 hrs |
|
Inhibition of 14-3-3sigma in human Ba/F3 cells expressing wild type Bcr-Abl construct assessed as release of full-length c-Abl from cytoplasmic complex with 14-3-3sigma at 1 uM after 24 hrs by immunoprecipitation/immunoblot technique |
21962576 |
Ba/F3 |
Function assay |
1 uM |
24 hrs |
|
Inhibition of 14-3-3sigma in human Ba/F3 cells expressing wild type Bcr-Abl construct assessed as nuclear import of full-length c-Abl at 1 uM after 24 hrs by immunoprecipitation/immunoblot technique |
21962576 |
K562 |
Function assay |
|
6 hrs |
|
Inhibition of BCR-ABL-mediated STAT5 phosphorylation in human K562 cells after 6 hrs by phospho-flow cytometry |
22148584 |
K562 |
Function assay |
40 uM |
6 hrs |
|
Inhibition of BCR-ABL-mediated ERK1 phosphorylation in human K562 cells at 40 uM after 6 hrs by phospho-flow cytometry |
22148584 |
K562 |
Function assay |
40 uM |
6 hrs |
|
Inhibition of BCR-ABL-mediated ERK2 phosphorylation in human K562 cells at 40 uM after 6 hrs by phospho-flow cytometry |
22148584 |
TF1 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human TF1 cells expressing c-KIT mutation assessed as cell viability, IC50=0.013μM. |
22221201 |
primary leukemia cells |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human primary leukemia cells isolated from acute myeloid leukemia patient expressing wild type FLT3 assessed as cell viability after 72 hrs by luciferase assay, IC50=0.1μM. |
22221201 |
primary leukemia cells |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human primary leukemia cells isolated from acute myeloid leukemia patient expressing FLT3-D835Y mutation assessed as cell viability after 72 hrs by luciferase assay, IC50=0.5μM. |
22221201 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human K562 cells, GI50=0.17μM. |
22439674 |
HUVEC |
Antiproliferative assay |
|
|
|
Antiproliferative activity against HUVEC cells, GI50=18.5μM. |
22439674 |
K562 |
Cytotoxicity assay |
|
24 hrs |
|
Cytotoxicity against human K562 cells after 24 hrs by MTT assay, IC50=0.1μM. |
22632935 |
K562 |
Cytotoxicity assay |
|
48 to 72 hrs |
|
Cytotoxicity against human BCR-ABL positive K562 cells after 48 to 72 hrs by MTT assay, IC50=0.3844μM. |
22789429 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells after 72 hrs by MTS assay, GI50=0.39μM. |
22932313 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl H396P mutant after 72 hrs by CCK-8 assay, IC50=0.11μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl M244V mutant after 72 hrs by CCK-8 assay, IC50=0.129μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl E355G mutant after 72 hrs by CCK-8 assay, IC50=0.362μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl M351T mutant after 72 hrs by CCK-8 assay, IC50=0.424μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl F359V mutant after 72 hrs by CCK-8 assay, IC50=0.96μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl Y253F mutant after 72 hrs by CCK-8 assay, IC50=1.444μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing wild type Bcr-Abl after 72 hrs by CCK-8 assay, IC50=1.834μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl G250E mutant after 72 hrs by CCK-8 assay, IC50=1.863μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl H396R mutant after 72 hrs by CCK-8 assay, IC50=2.377μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl F486S mutant after 72 hrs by CCK-8 assay, IC50=2.547μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl E255K mutant after 72 hrs by CCK-8 assay, IC50=2.951μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl T315I mutant after 72 hrs by CCK-8 assay, IC50=3.005μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl Q252H mutant after 72 hrs by CCK-8 assay, IC50=3.763μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl E255V mutant after 72 hrs by CCK-8 assay, IC50=8.615μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl Y253H mutant after 72 hrs by CCK-8 assay, IC50=17.083μM. |
23088644 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells after 72 hrs by CCK-8 assay, IC50=18.52μM. |
23088644 |
MDCK2 |
Function assay |
|
5 mins |
|
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis, IC50=0.04μM. |
23241029 |
HEK293 |
Function assay |
|
1.5 mins |
|
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis, IC50=0.05μM. |
23241029 |
HEK293 |
Function assay |
500 uM |
1.5 mins |
|
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay, IC50=0.35μM. |
23241029 |
HEK293 |
Function assay |
|
1.5 mins |
|
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay, IC50=0.35μM. |
23241029 |
HEK293 |
Function assay |
|
1.5 mins |
|
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay, IC50=2.9μM. |
23241029 |
HEK293 |
Function assay |
|
3 mins |
|
Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay, IC50=4.2μM. |
23241029 |
HEK293 |
Function assay |
|
3 mins |
|
Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay, IC50=25.5μM. |
23241029 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant wild type ABL1 expressed in insect cells after 30 mins by FRET assay, IC50=0.0982μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 M351T mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.1143μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 Q252H mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.115μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 H396P mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.1739μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL M351T mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=0.24μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 G250E mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.3599μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 E255K mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.4858μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing wild type BCR-ABL assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=0.5μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL E359V mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=0.59μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 Y253F mutant expressed in insect cells after 30 mins by FRET assay, IC50=0.7496μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL F486S mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=1μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL E355G mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=1.6μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL F317L mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=3.3μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL Q252H mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=3.6μM. |
23301703 |
insect cells |
Function assay |
|
30 mins |
|
Inhibition of human recombinant ABL1 T315I mutant expressed in insect cells after 30 mins by FRET assay, IC50=5.155μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL G250E mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=5.2μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL E255K mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=5.6μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL Y253F mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=9.2μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL F317V mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=9.5μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL H396R mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=11.1μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL T315I mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=12.2μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL L248V mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=12.2μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells expressing BCR-ABL Y253H mutant assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=12.5μM. |
23301703 |
BA/F3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CCK-8 assay, IC50=13.5μM. |
23301703 |
BA/F3 |
Antitumor assay |
50 mg/kg |
14 days |
|
Antitumor activity against mouse BA/F3 cells expressing wild type BCR-ABL allografted in SCID mouse assessed as inhibition of tumor growth at 50 mg/kg, po qd for 14 days |
23301703 |
K562 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human K562 cells, IC50=0.5μM. |
23352483 |
BA/F3 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against mouse BA/F3 cells transfected with wild type Bcr-Abl after 48 hrs by XTT assay, IC50=0.092μM. |
23600806 |
K562 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human K562 cells, IC50=0.17μM. |
23600806 |
BA/F3 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against mouse BA/F3 cells transfected with Bcr-Abl T315I mutant after 48 hrs by XTT assay, IC50=4.79μM. |
23600806 |
Ba/F3 |
Function assay |
|
1 hr |
|
Inhibition of Bcr-Abl T315I mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction of phosphorylated CrkL level after 1 hr by Western blot analysis |
23600806 |
Ba/F3 |
Function assay |
|
1 hr |
|
Inhibition of Bcr-Abl T315I mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction of phosphorylated STAT5 level after 1 hr by Western blot analysis |
23600806 |
Ba/F3 |
Function assay |
|
1 hr |
|
Inhibition of Bcr-Abl T315I mutant (unknown origin) phosphorylation transfected in mouse Ba/F3 cells after 1 hr by Western blot analysis |
23600806 |
GIST882 |
Function assay |
|
|
|
Inhibition of KIT K642E mutant autophosphorylation (unknown origin) expressed in human GIST882 cells by ELISA, IC50=0.097μM. |
23611771 |
GIST882 |
Function assay |
|
|
|
Inhibition of KIT K642E mutant (unknown origin) expressed in human GIST882 cells assessed as cell growth inhibition by ATP-depletion assay, IC50=0.108μM. |
23611771 |
32D |
Function assay |
|
|
|
Inhibition of human BCR-ABL1 (unknown origin) expressed in mouse 32D cells, IC50=0.194μM. |
23611771 |
BA/F3 |
Function assay |
|
|
|
Inhibition of human BCR-ABL1 autophosphorylation expressed in mouse BA/F3 cells by ELISA, IC50=0.221μM. |
23611771 |
BA/F3 |
Function assay |
|
|
|
Inhibition of human BCR-ABL1 expressed in mouse BA/F3 cells assessed as cell growth inhibition by ATP-depletion assay, IC50=0.678μM. |
23611771 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human K562 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50=0.47μM. |
23735826 |
GISTT1 |
Function assay |
|
72 hrs |
|
Inhibition of KIT in human GISTT1 cells assessed as growth inhibition after 72 hrs by SRB assay, GI50=0.01μM. |
23773153 |
GIST48B |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human GIST48B cells after 72 hrs by SRB assay, GI50=20μM. |
23773153 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=0.5μM. |
23932071 |
HepG2 |
Antiproliferative assay |
|
24 to 96 hrs |
|
Antiproliferative activity against human HepG2 cells after 24 to 96 hrs by MTS assay, IC50=10μM. |
23932071 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells after 72 hrs by calcein-AM assay, IC50=0.5μM. |
23981532 |
Sf9 |
Function assay |
|
|
|
Inhibition of recombinant Abl kinase (unknown origin) expressed in Sf9 cells using GGEAIYAAPFKK as substrate in presence of [gamma33P]ATP, IC50=0.3μM. |
24681986 |
K562 |
Antiproliferative assay |
|
24 hrs |
|
In vitro antiproliferative activity against human K562 cells assessed as decrease in cell viability after 24 hrs by MTT assay, IC50=13μM. |
24681986 |
BV173 |
Antiproliferative assay |
|
24 hrs |
|
In vitro antiproliferative activity against human BV173 cells assessed as decrease in cell viability after 24 hrs by MTT assay, IC50=20μM. |
24681986 |
CCRF-CEM |
Antiproliferative assay |
|
24 hrs |
|
In vitro antiproliferative activity against human CCRF-CEM cells assessed as decrease in cell viability after 24 hrs by MTT assay, IC50=45μM. |
24681986 |
K562 |
Function assay |
10 uM |
1 hr |
|
Inhibition of Bcr/Abl kinase tyrosine phosphorylation in human K562 cells at 10 uM after 1 hr by immunoblot analysis |
24681986 |
K562 |
Function assay |
10 uM |
1 hr |
|
Inhibition of Abl kinase tyrosine phosphorylation in human K562 cells at 10 uM after 1 hr by immunoblot analysis |
24681986 |
K562 |
Function assay |
10 uM |
1 hr |
|
Inhibition of tyrosine phosphorylation of protein with molecular weight between 40 and 60 kDa in human K562 cells at 10 uM after 1 hr by immunoblot analysis |
24681986 |
HGC27 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against HGC27 cells assessed as cell viability after 48 hrs by MTT assay, IC50=3.8μM. |
24900584 |
HMC-1.2 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human HMC-1.2 cells carrying V560G, D816V mutant assessed as cell growth inhibition by MTT assay, IC50=17μM. |
25004409 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against Bcr/Abl positive human K562 cells after 48 hrs by MTT method, IC50=4.12μM. |
25464886 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells after 72 hrs using Calcein AM by fluorescence assay, IC50=0.5μM. |
25757603 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=0.47μM. |
25778766 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells expressing wild type Bcr-Abl after 72 hrs by CCK-8 assay, IC50=0.28μM. |
26195136 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=1.16μM. |
26231079 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against imatinib-resistant human K562 cells after 48 hrs by MTT assay, IC50=15.7μM. |
26231079 |
K562 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human K562 cells assessed as reduction in cell viability, IC50=0.06μM. |
26264503 |
IR-K562 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against imatinib resistant human IR-K562 cells assessed as reduction in cell viability, IC50=1.1μM. |
26264503 |
HEK293 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against HEK293 cells assessed as reduction in cell viability, CC50=8.4μM. |
26264503 |
U937 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human U937 cells assessed as reduction in cell viability, IC50=19μM. |
26264503 |
THP1 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human THP1 cells assessed as reduction in cell viability, IC50=25μM. |
26264503 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=4.12μM. |
26298495 |
HCT116 |
Anticancer assay |
|
|
|
Anticancer activity against human HCT116 cells, IC50=34.4μM. |
26312434 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human K562 cells expressing Bcr-Abl assessed as growth inhibition after 48 hrs by MTT assay, IC50=1.16μM. |
26451772 |
BA/F3 |
Growth inhibition assay |
|
48 hrs |
|
Growth inhibition of mouse BA/F3 cells expressing wild-type Bcr-Abl after 48 hrs by MTT assay, IC50=0.089μM. |
26562217 |
BA/F3 |
Growth inhibition assay |
|
48 hrs |
|
Growth inhibition of mouse BA/F3 cells expressing Bcr-Abl T315I mutant after 48 hrs by MTT assay, IC50=14.5μM. |
26562217 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by trypan blue dye exclusion assay, IC50=0.22μM. |
26629859 |
K562 |
Apoptosis assay |
|
48 hrs |
|
Induction of apoptosis in human K562 cells after 48 hrs by annexinV and propidium iodide staining based flow cytometry, AC50=0.68μM. |
26629859 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay, IC50=0.53μM. |
26707846 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells assessed as cell viability after 72 hrs by fluorescence microplate reader method, IC50=0.73μM. |
26741853 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells assessed as cell viability after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.14μM. |
26789553 |
KU812 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human KU812 cells assessed as cell viability after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.16μM. |
26789553 |
MEG01 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human MEG01 cells assessed as cell viability after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.24μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.38μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-LCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.5μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-M351T mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.625μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-Q252H mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.659μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-F317I mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.855μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-H369P mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=1.69μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-E255K mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=1.93μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-SRC (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=2.1μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210-F317L mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=2.169μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-DDR1 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=3μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-BLK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=4.1μM. |
26789553 |
HEL |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human HEL cells assessed as cell viability after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=5.3μM. |
26789553 |
BA/F3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BA/F3 cells assessed as cell viability after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=6.7μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-DDR2 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=7.7μM. |
26789553 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-HCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=9.7μM. |
26789553 |
Neuro2a |
Function assay |
1 uM |
|
|
Inhibition of DR24 in Dhcr7-deficient mouse Neuro2a cells assessed as decrease in 7-DHC levels at 1 uM by LC-MS/GC-MS analysis |
26789657 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells assessed as cell viability after 72 hrs by MTT assay, IC50=0.51μM. |
26814890 |
K562/G |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562/G cells assessed as cell viability after 72 hrs by MTT assay, IC50=4.65μM. |
26814890 |
BA/F3 |
Function assay |
|
48 hrs |
|
Inhibition of imatinib-resistant PDGFR D842V mutant (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by CellTiter 96 aqueous one solution cell proliferation assay, IC50=0.642μM. |
26844689 |
HL60 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human HL60 cells assessed as inhibition of cell survival after 72 hrs by MTT assay, IC50=0.03μM. |
26850004 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell survival after 72 hrs by MTT assay, IC50=0.38μM. |
26850004 |
KG1a |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human KG1a cells assessed as inhibition of cell survival after 72 hrs by MTT assay, IC50=16.7μM. |
26850004 |
293T |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human 293T cells assessed as growth inhibition, CC50=20.53μM. |
26850004 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of human wild type BCR-ABL expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay, EC50=0.034μM. |
27010810 |
JURL-MK1 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human JURL-MK1 cells after 48 hrs by Cell-Titer-Glo luminescent cell viability assay, GI50=0.06μM. |
27011159 |
BV173 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human BV173 cells after 48 hrs by Cell-Titer-Glo luminescent cell viability assay, GI50=0.1μM. |
27011159 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by Cell-Titer-Glo luminescent cell viability assay, GI50=0.2μM. |
27011159 |
EM2 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human EM2 cells after 48 hrs by Cell-Titer-Glo luminescent cell viability assay, GI50=0.26μM. |
27011159 |
KCL22 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human KCL22 cells after 48 hrs by Cell-Titer-Glo luminescent cell viability assay, GI50=0.43μM. |
27011159 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against cKIT dependent human GISTT1 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.008μM. |
27077705 |
GIST882 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against cKIT dependent human GIST882 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.014μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT V559D mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.039μM. |
27077705 |
MEG01 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human BCR-ABL dependent MEG01 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.074μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT L567P mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.1μM. |
27077705 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against BCR-ABL dependent human K562 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.12μM. |
27077705 |
KU812 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against BCR-ABL dependent human KU812 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.16μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=0.4μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT N822K mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=1.29μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT V654A mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=2.49μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT V559D/V654A double mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=3μM. |
27077705 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused cKIT T670I/V559D double mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50=6.67μM. |
27077705 |
K562 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human K562 cells, IC50=0.5μM. |
27189674 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells assessed as decrease in cell proliferation after 72 hrs by XTT assay, IC50=0.31μM. |
27214512 |
A10 |
Function assay |
|
68 hrs |
|
Inhibition of PDGFR-beta driven proliferation of rat A10 cells after 68 hrs in presence of rat recombinant PDGF-BB by cell titer-glo luminescence assay, IC50=0.162μM. |
27502700 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT L567P mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.01μM. |
27545040 |
GIST-T1 |
Function assay |
|
72 hrs |
|
Inhibition of wild type cKIT in human GIST-T1 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.027μM. |
27545040 |
Sf9 |
Function assay |
|
1 hr |
|
Inhibition of His-tagged cKIT (unknown origin) expressed in Sf9 cells using Poly(4:1 Glu, Tyr) peptide as substrate after 1 hr by ADP-glo kinase assay, IC50=0.319μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT N822K mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.36μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.59μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT V654A mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.7μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT V559D/V654A double mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.7μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT T670I/V559D double mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=5.2μM. |
27545040 |
GIST-5R |
Function assay |
|
72 hrs |
|
Inhibition of wild type cKIT T670I mutant in human GIST-5R cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=8.3μM. |
27545040 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT T670I mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=9.6μM. |
27545040 |
Sf9 |
Function assay |
|
1 hr |
|
Inhibition of His-tagged cKIT T670I mutant (544 to 935 residues) (unknown origin) expressed in Sf9 cells using Poly(4:1 Glu, Tyr) peptide as substrate after 1 hr by ADP-glo kinase assay, IC50=9.818μM. |
27545040 |
K562 |
Function assay |
100 uM |
8 hrs |
|
Inhibition of BCR-ABL signaling pathway in human K562 cells assessed as suppression of STAT5 phosphorylation at 100 uM after 8 hrs in presence of MeBS by Western blot analysis |
27666635 |
K562 |
Function assay |
100 uM |
8 hrs |
|
Inhibition of BCR-ABL in signaling pathway human K562 cells assessed as suppression of CrkL phosphorylation at 100 uM after 8 hrs in presence of MeBS by Western blot analysis |
27666635 |
K562 |
Function assay |
100 uM |
8 hrs |
|
Inhibition of BCR-ABL phosphorylation in human K562 cells at 100 uM after 8 hrs in presence of MeBS by Western blot analysis |
27666635 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GISTT1 cells measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.008μM. |
27966954 |
GIST882 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GIST882 cells measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.014μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused PDGFR-beta (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.019μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused PDGFR-alpha (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.034μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT V559D mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.039μM. |
27966954 |
MEG01 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human MEG01 cells measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.074μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT L576P mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.102μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused CSF1R (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.11μM. |
27966954 |
KU812 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human KU812 cells measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.163μM. |
27966954 |
SF9 |
Function assay |
|
1 hr |
|
Inhibition of C-terminal His-tagged human ABL1 expressed in baculovirus infected SF9 cells using Tyr 02 peptide as substrate measured after 1 hr by FRET based Z'Lyte assay, IC50=0.223μM. |
27966954 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.267μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of human BCR/ABL p210 fusion protein expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.27μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.37μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210 fusion protein M356T mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.625μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210 fusion protein F317I mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=0.85μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT N822K mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=1.29μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210 fusion protein H369P mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=1.79μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL p210 fusion protein F317L mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=2.16μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT V654A mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=2.49μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT V559D/V654A double mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=3μM. |
27966954 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of Tel-fused c-KIT T670I mutant (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay, GI50=6.67μM. |
27966954 |
K562 |
Cell cycle assay |
1 uM |
24 hrs |
|
Cell cycle arrest in human K562 cells assessed as accumulation at G0/G1 phase at 1 uM after 24 hrs by propidium iodide/RNase staining based flow cytometry |
27966954 |
KU812 |
Cell cycle assay |
1 uM |
12 hrs |
|
Cell cycle arrest in human KU812 cells assessed as accumulation at G0/G1 phase at 1 uM after 12 hrs by propidium iodide/RNase staining based flow cytometry |
27966954 |
MEG01 |
Cell cycle assay |
1 uM |
24 hrs |
|
Cell cycle arrest in human MEG01 cells assessed as accumulation at G0/G1 phase at 1 uM after 24 hrs by propidium iodide/RNase staining based flow cytometry |
27966954 |
GISTT1 |
Cell cycle assay |
1 uM |
24 hrs |
|
Cell cycle arrest in human GISTT1 cells assessed as accumulation at G0/G1 phase at 1 uM after 24 hrs by propidium iodide/RNase staining based flow cytometry |
27966954 |
GIST882 |
Cell cycle assay |
1 uM |
48 hrs |
|
Cell cycle arrest in human GIST882 cells assessed as accumulation at G0/G1 phase at 1 uM after 48 hrs by propidium iodide/RNase staining based flow cytometry |
27966954 |
K562 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human K562 cells assessed as cleavage of PARP at 1 uM by Western blot analysis |
27966954 |
K562 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human K562 cells assessed as increase in cleaved caspase-3 level at 1 uM by Western blot analysis |
27966954 |
KU812 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human KU812 cells assessed as cleavage of PARP at 1 uM by Western blot analysis |
27966954 |
KU812 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human KU812 cells assessed as increase in cleaved caspase-3 level at 1 uM by Western blot analysis |
27966954 |
MEG01 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human MEG01 cells assessed as increase in cleaved caspase-3 level at 1 uM by Western blot analysis |
27966954 |
GISTT1 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human GISTT1 cells assessed as increase in cleaved caspase-3 level at 1 uM by Western blot analysis |
27966954 |
MEG01 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human MEG01 cells assessed as cleavage of PARP at 1 uM by Western blot analysis |
27966954 |
GISTT1 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human GISTT1 cells assessed as cleavage of PARP at 1 uM by Western blot analysis |
27966954 |
GIST882 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human GIST882 cells assessed as cleavage of PARP at 1 uM by Western blot analysis |
27966954 |
GIST882 |
Apoptosis assay |
1 uM |
|
|
Induction of apoptosis in human GIST882 cells assessed as increase in cleaved caspase-3 level at 1 uM by Western blot analysis |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in AKT phosphorylation at S473 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y703 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y719 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y823 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y703 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y719 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT autophosphorylation at Y823 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in AKT phosphorylation at S473 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in ERK1/2 phosphorylation at T202/Y204 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in Stat3/5 phosphorylation at Y705/Y694 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in S6 phosphorylation at S235/236 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GISTT1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in S6K phosphorylation at T389 in human GISTT1 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in Stat3/5 phosphorylation at Y705/Y694 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in ERK1/2 phosphorylation at T202/Y204 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in S6 phosphorylation at S235/236 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
GIST882 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of c-KIT mediated signaling pathways assessed as reduction in S6K phosphorylation at T389 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting |
27966954 |
K562 |
Function assay |
|
30 mins |
|
Inhibition of kinobead binding to NQO2 in human K562 cells incubated for 30 mins by iTRAQ reagent-based mass spectrometric method, IC50=0.043μM. |
28280261 |
K562 |
Function assay |
|
30 mins |
|
Inhibition of kinobead binding to DDR1 in human K562 cells incubated for 30 mins by iTRAQ reagent-based mass spectrometric method, IC50=0.09μM. |
28280261 |
K562 |
Function assay |
|
30 mins |
|
Inhibition of kinobead binding to ABL in human K562 cells incubated for 30 mins by iTRAQ reagent-based mass spectrometric method, IC50=0.25μM. |
28280261 |
K562 |
Function assay |
|
30 mins |
|
Inhibition of kinobead binding to ARG in human K562 cells incubated for 30 mins by iTRAQ reagent-based mass spectrometric method, IC50=0.272μM. |
28280261 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay, IC50=0.53μM. |
28525838 |
A549 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay, IC50=4.56μM. |
28525838 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GISTT1 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.003μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.0107μM. |
28541695 |
GIST882 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GIST882 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.02μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT C674S mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.0249μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT V559D mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.036μM. |
28541695 |
MEG01 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human MEG01 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.045μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT L576P mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.0451μM. |
28541695 |
KU812 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human KU812 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.11μM. |
28541695 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.147μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT A829P mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.1482μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.3819μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT V559D/V654A double mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.803μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT V654A mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=0.8031μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT D816H mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=1.245μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused cKIT N822K mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=1.466μM. |
28541695 |
BAF3 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=4.686μM. |
28541695 |
GIST48B |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GIST48B cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay, GI50=6.986μM. |
28541695 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of ABL in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTT assay, IC50=0.73μM. |
28974338 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of ABL T315I mutant in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTT assay, IC50=20.03μM. |
28974338 |
GISTT1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human GISTT1 cells assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50=0.04μM. |
28991465 |
GIST430 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human GIST430 cells harboring KIT V654A mutant assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50=1.1μM. |
28991465 |
Sf9 |
Function assay |
|
|
|
Binding affinity to recombinant full length human N-terminal GST-tagged Syk-KD (356 to 635 residues) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells using poly EY 4:1 as substrate, Ki=5μM. |
29132752 |
DAOY |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells |
29435139 |
EOL-1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human EOL-1 cells after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50<0.001μM. |
29544149 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.019μM. |
29544149 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.034μM. |
29544149 |
NCI-H1703 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human NCI-H1703 cells after 72 hrs in presence of PDGF-AA by CellTiter-Glo or CCK-8 assay, GI50=0.23μM. |
29544149 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused c-KIT (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=0.37μM. |
29544149 |
NCI-H1703 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human NCI-H1703 cells after 72 hrs by CellTiter-Glo or CCK-8 assay, GI50=2.1μM. |
29544149 |
NCI-H1703 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y1018 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis |
29544149 |
NCI-H1703 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y754 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis |
29544149 |
NCI-H1703 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y849 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis |
29544149 |
EOL-1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT5 phosphorylation at Y694 residue at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis |
29544149 |
EOL-1 |
Function assay |
1 uM |
2 hrs |
|
Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK phosphorylation at T202/Y204 residues at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis |
29544149 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity in drug sensitive human K562 cells assessed as reduction cell viability incubated for 48 hrs by XTT assay, IC50=1.1μM. |
29655981 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay, IC50=3.43μM. |
29684708 |
MCF7 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay, IC50=7.12μM. |
29684708 |
A2780 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human A2780 cells after 72 hrs by MTT assay, IC50=8.9μM. |
29684708 |
HCT116 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=19.66μM. |
29684708 |
HT-29 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human HT-29 cells after 96 hrs by SRB assay, IC50=0.06μM. |
29724653 |
GIST882 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against imatinib-susceptible human GIST882 cells harboring c-KIT K642E mutant after 96 hrs by SRB assay, IC50=1.7μM. |
29724653 |
HGC27 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human HGC27 cells after 96 hrs by SRB assay, IC50=2.4μM. |
29724653 |
MCF7 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against human MCF7 cells after 96 hrs by SRB assay, IC50=11.3μM. |
29724653 |
GIST48 |
Antiproliferative assay |
|
96 hrs |
|
Antiproliferative activity against imatinib-resistant human GIST48 cells harboring c-KIT V560D/D820A double mutant after 96 hrs by SRB assay, IC50=19.8μM. |
29724653 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 G250H mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.0771μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of wild type BCR-ABL1 (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.0905μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 E355G mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.149μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 E459K mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.201μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 F359V mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.249μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 Q252H mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.455μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 Y253H mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.836μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 E255K mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.838μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 E255V mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of BCR-ABL1-mediated cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=0.874μM. |
30137981 |
Ba/F3 |
Function assay |
|
48 hrs |
|
Inhibition of BCR-ABL1 T315I mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of cell proliferation after 48 hrs by BriteLight luciferase assay, GI50=9.645μM. |
30137981 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.017μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.046μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit V560D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.07μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.102μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 9 AY502 to 503 insertion mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.192μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and D820A mutant and D820A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.216μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and N822K mutant and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.223μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and A829P mutant and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.312μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and V654A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.392μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and D816H mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.535μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.567μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (557 to 558 residues) and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.669μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit V560D/V654A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=0.701μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit V560D/D816H mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=1.191μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 11 deletion (560 to 578 residues) mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=1.523μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 9 AY502 to 503 insertion and D816 mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=2.749μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit exon 9 AY502 to 503 insertion and V654 mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=3.947μM. |
30204441 |
BA/F3 |
Function assay |
|
72 hrs |
|
Inhibition of Kit D816V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50=9.93μM. |
30204441 |
K562 |
Cytotoxicity assay |
|
24 hrs |
|
Cytotoxicity against imatinib-sensitive human K562 cells assessed as decrease in cell viability after 24 hrs by XTT assay, IC50=1μM. |
30261468 |
K562 |
Function assay |
1 uM |
|
|
Inhibition of BCR-ABL in imatinib-sensitive human K562 cells assessed as decrease in CrKL phosphorylation at 1 uM by immuno blot analysis |
30261468 |
Sf9 |
Function assay |
|
60 mins |
|
Inhibition of inactive wild type His-tagged ABL (229 to 500 residues) (unknown origin) expressed in baculovirus infected sf9 cells assessed as reduction in autophosphorylation preincubated for 60 mins followed by ATP addition measured after 8 hrs by ADP-G, IC50=0.043μM. |
30317026 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity in human K562 cells after 72 hrs by CCK8 assay, GI50=0.25μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of wild type C-terminal FLAG-tagged human TEL fused ABL (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.26μM. |
30317026 |
MEG01 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity in human MEG01 cells after 72 hrs by CCK8 assay, GI50=0.28μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of wild type BCR/ABL (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.29μM. |
30317026 |
KU812 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity in human KU812 cells after 72 hrs by CCK8 assay, GI50=0.31μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL V299L mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.65μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL M351T mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.85μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL F317I mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.95μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL Q252H mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=1.17μM. |
30317026 |
Sf9 |
Function assay |
|
1 hr |
|
Inhibition of active wild type His-tagged ABL (229 to 500 residues) (unknown origin) expressed in baculovirus infected sf9 cells using ABLtide as substrate after 1 hr by ADP-Glo assay, IC50=1.5μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL F317L mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=2.24μM. |
30317026 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/ABL H369P mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=3.75μM. |
30317026 |
HCT116 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against p53+/+ human HCT116 cells after 72 hrs by CellTiter 96 aqueous one solution assay, IC50=44.55μM. |
30562697 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay, IC50=0.00015μM. |
30605831 |
MCF7 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay, IC50=6.33μM. |
30798049 |
MDA-MB-453 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MDA-MB-453 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay, IC50=12.84μM. |
30798049 |
GIST882 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST882 cells harboring c-KIT exon 13 homozygous primary K642E mutant assessed as reduction in cell viability by MTS assay, GI50=0.195μM. |
30968693 |
GIST882 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST882 cells harboring c-KIT exon 13 homozygous primary K642E mutant assessed as reduction in cell viability by methylene blue staining based assay, GI50=0.195μM. |
30968693 |
GIST48 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST48 cells harboring c-KIT exon 11 homozygous primary missense V560D mutant and exon 17 heterozygous secondary D820A mutant assessed as reduction in cell viability by MTS assay, GI50=0.625μM. |
30968693 |
GIST48 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST48 cells harboring c-KIT exon 11 homozygous primary missense V560D mutant and exon 17 heterozygous secondary D820A mutant assessed as reduction in cell viability by methylene blue staining based assay, GI50=0.625μM. |
30968693 |
Sf9 |
Function assay |
|
|
|
Inhibition of unactivated recombinant human N-terminal 6x-His-tagged c-KIT (547 to 935 residues)/(694 to 753 residues deletion) expressed in baculovirus infected Sf9 insect cells assessed as decrease in poly (Glu,Tyr) 4:1 phosphorylation, IC50=0.769μM. |
30968693 |
GIST430 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as reduction in cell viability by MTS assay, GI50=0.929μM. |
30968693 |
GIST430 |
Antiproliferative assay |
|
|
|
Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as reduction in cell viability by methylene blue staining based assay, GI50=0.929μM. |
30968693 |
Sf9 |
Function assay |
|
|
|
Inhibition of ATP-activated recombinant human N-terminal 6x-His-tagged c-KIT (547 to 935 residues)/(694 to 753 residues deletion) expressed in baculovirus infected Sf9 insect cells assessed as decrease in poly (Glu,Tyr) 4:1 phosphorylation, IC50=5.21μM. |
30968693 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT V559G mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.001μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT V559A mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.005μM. |
31046271 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant incubated for 72 hrs by CCK8 assay, GI50=0.026μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT V559D mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.039μM. |
31046271 |
GIST882 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GIST882 cells harboring c-KIT K642E mutant incubated for 72 hrs by CCK8 assay, GI50=0.058μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT L576P mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.115μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT D820E mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.267μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of wild type TEL fused c-KIT (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.364μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT A829P mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.406μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT D816H mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.823μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT N822K mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=1.29μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT V654A/V559D double mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=1.57μM. |
31046271 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of TEL fused c-KIT V654A mutant (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=2.3μM. |
31046271 |
K562 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell viability incubated for 72 hrs by real time live-cell imaging technique, IC50=0.14μM. |
31097376 |
K562 |
Apoptosis assay |
10 uM |
48 hrs |
|
Induction of apoptosis in human K562 cells assessed as increase in apoptotic cells at 10 uM incubated for 48 hrs by Caspase-3/7 reagent-based fluorescence assay |
31097376 |
K562 |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human BCR/ABL positive K562 cells assessed as growth inhibition measured after 48 hrs by MTT assay, IC50=4.26μM. |
31185413 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V560D mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.003μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V559G mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.008μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V559D mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.01μM. |
31250638 |
GISTT1 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT 560 to 578 deletion mutant in human GISTT1 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.015μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT D820E mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.035μM. |
31250638 |
GIST882 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT K642E mutant in human GIST882 cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.048μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT L576P mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.085μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT S709F mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.115μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT D816E mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.174μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT D820G mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.337μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.35μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT D820Y mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.435μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT A829P mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.58μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V654A/V559D double mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.608μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT D816H mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.651μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V559A mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=0.905μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT V654A mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=1.41μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT N822K mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=1.47μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT T670E mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=4.08μM. |
31250638 |
BAF3 |
Function assay |
|
72 hrs |
|
Inhibition of c-KIT Y823D mutant in mouse BAF3(transformed) cells assessed as growth inhibition after 72 hrs by CCK8 assay, GI50=5.87μM. |
31250638 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant measured after 72 hrs by CCK8 assay |
31250638 |
EOL-1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against FIP1L1-PDGFRA positive human EOL-1 cells assessed as growth inhibition after 72 hrs by resazurin dye-based fluorescence analysis, GI50<0.0005μM. |
31514019 |
K562 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by resazurin dye-based fluorescence analysis, GI50=0.73μM. |
31514019 |
CEM |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human CEM cells assessed as growth inhibition after 72 hrs by resazurin dye-based fluorescence analysis, GI50=35.809μM. |
31514019 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of wild type BCR/Abl (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.1438μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl P230 mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.2215μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl P190 mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.3455μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl F317I mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.364μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl V299L mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.4053μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl Q252H mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.4865μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl F317L mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.7163μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl M351T mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=0.7993μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl H396P mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=2.706μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl E255K mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=3.257μM. |
31699612 |
Ba/F3 |
Function assay |
|
72 hrs |
|
Inhibition of BCR/Abl Y253F mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as inhibition of cell proliferation measured after 72 hrs by CellTiter-Glo luminescent cell viability assay, IC50=8.778μM. |
31699612 |
GISTT1 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human GISTT1 cells harboring heterozygous deletion mutation at C-kit exon 11 assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay, GI50=0.04μM. |
31721578 |
Sf9 |
Function assay |
|
150 mins |
|
Inhibition of recombinant N-terminal 6x-His-tagged c-KIT (547 to 935 residues)/(694 to 753 residues deletion) (unknown origin) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate measured after 150 mins in presence of , IC50=0.053μM. |
31721578 |
Sf9 |
Function assay |
|
4 hrs |
|
Inhibition of wild type recombinant GST-tagged FLT3 (Y567 to S993 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using Her2 peptide as substrate measured after 4 hrs in presence of ATP by Kinase-Glo Plus reagent-based lumine, IC50=0.131μM. |
31721578 |
GIST882 |
Antiproliferative assay |
|
144 hrs |
|
Antiproliferative activity against human GIST882 cells harboring c-KIT exon 13 homozygous primary K642E mutant assessed as cell growth inhibition after 144 hrs by methylene blue staining based assay, GI50=0.195μM. |
31721578 |
GIST430 |
Antiproliferative assay |
|
120 hrs |
|
Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as cell growth inhibition after 120 hrs by methylene blue staining , GI50=0.625μM. |
31721578 |
GIST48 |
Antiproliferative assay |
|
120 hrs |
|
Antiproliferative activity against human GIST48 cells harboring c-KIT exon 11 homozygous primary missense V560D mutant and exon 17 heterozygous secondary D820A mutant assessed as cell growth inhibition after 120 hrs by methylene blue staining based assay, GI50=0.929μM. |
31721578 |